An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Clinical trial NCT05592483 · TERMINATED
Trial details
- NCT number
- NCT05592483
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-07
- Primary completion
- 2024-05-29
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.